Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Retroperitoneal liposarcoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Blast Crisis 2 Retroperitoneal liposarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Mastocytosis, Systemic 1 Liposarcoma 1 Leukemia 1 Leiomyosarcoma 1 Hypereosinophilic Syndrome 1 Chondrosarcoma 1

Interventions

nilotinib 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡